TheGuardian

JUNE 15, 2021

Being big in vaccines was never part of chief executive Pascal Soriot’s grand plan for AstraZeneca, so there’s a decision to be made about what to do with an operation that has been built almost by accident during a global emergency. The long term, though, is another matter. Continue reading.

Strategy 79

Strategy Operations Company Taxes 79

TheGuardian

JULY 30, 2020

Companies can return to work from 1 August, but many employers are making their own plans Companies ready to defy Boris Johnson’s planned return to work Future shape of offices: proposals to make workplaces safe Major companies in England have been told that, from 1 August, they can discuss with workers whether it is safe to return to work.

Company 85

Company Industry Groups National 85

TheGuardian

MARCH 24, 2021

Drugmaker isn’t entirely blameless but making it a political football for EU’s failures is simply ugly The European Union ought to be delighted. The “discovery” of a “stockpile” of 29m vaccine doses in Italy is really a non-discovery. The consignment is held at an authorised plant, available for inspection, and is merely awaiting quality signoff.

Industry 65

Industry Retail 65

TheGuardian

MAY 2, 2020

The partnership between AstraZeneca and the Jenner Institute should jolt our industry and banks Coronavirus latest updates See all our coronavirus coverage There was some good news last week.

Course 77

Course National Industry Company 77

TheGuardian

APRIL 28, 2021

The cry: “Why can’t the company be more like AstraZeneca?” AstraZeneca’s shares have soared in the period; GSK’s have gone roughly sideways. That phenomenon will be around for a while and was expected, but weary shareholders may reflect (again) that there is always something at GSK. has been heard for half a decade for a reason.

Policies 44

Policies US Management Company 44

MyBankTracker

JULY 15, 2020

With the onset of the coronavirus pandemic, many people have gained an interest in investing in pharmaceutical companies like Moderna and AstraZeneca. However, unsuccessful trials can lead to major losses, so it’s important to understand the business you’re investing in, and the risk, before you jump in.

How To 52

How To Analysis Taxes Strategy 52

MyBankTracker

JULY 15, 2020

With the onset of the coronavirus pandemic, many people have gained an interest in investing in pharmaceutical companies like Moderna and AstraZeneca. However, unsuccessful trials can lead to major losses, so it’s important to understand the business you’re investing in, and the risk, before you jump in.

How To 52

How To Analysis Strategy Company 52

TrustBank

SEPTEMBER 18, 2020

The three vaccines that are currently in advanced stage clinical trials in the US are from Pfizer (PFE), Moderna (MRNA) and AstraZeneca (AZN). AstraZeneca (AZN) and the University of Oxford conducted an early study on monkeys and found that the vaccine provided protection. The United States awarded the project $1.2 billion in support.

Marketing 98

Marketing United States Washington Study 98

Jeff For Banks

NOVEMBER 16, 2020

He encourages leaders to let businesses reopen, so they can generate revenues and rehire employees. Small businesses are behind in rent and building owners have sought deferrals of their payments to lenders. Stop the economic devastation from the lockdowns. Despite the improvement in the unemployment rate to 6.9%

Marketing 78

Marketing National New York City Taxes 78